Reid Lofgran, DO
Family Medicine · Gooding, IDNPI 1144321753
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,200 of the $11,648 with a category attached, or 79.0%. Indivior Inc. accounts for 96.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $7,802 and has fallen 99.0% since, to $76 in 2025. Among family medicine clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $253.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$11K
- AbbVie$111
- Novo Nordisk$77
- Alkermes, Inc.$56
- Exact Sciences$55
- Amgen$22
- plus $73 from 5 others
What the payments were for
- Speaking & faculty fees$9,20079%
- Travel & lodging$1,26511%
- Food & beverage$1,18310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 27 | $11,254 |
| AbbVie | 2 | $111 |
| Novo Nordisk | 5 | $77 |
| Alkermes, Inc. | 3 | $56 |
| Exact Sciences | 3 | $55 |
| Amgen | 1 | $22 |
| Vertex | 1 | $20 |
| Boston Scientific | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| AstraZeneca | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUBLOCADE$10,987
How this compares
$11,648 in reported general payments places this provider in the 95th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 52 | $46,343 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 176 | $43,348 |
| JardianceEmpagliflozin | 52 | $39,304 |
| SublocadeBuprenorphine | 15 | $30,398 |
| VivitrolNaltrexone Microspheres | 11 | $17,458 |
| VraylarCariprazine Hcl | 13 | $17,456 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $17,236 |
| TrulicityDulaglutide | 13 | $16,695 |
| JanuviaSitagliptin Phosphate | 19 | $16,676 |
| XareltoRivaroxaban | 14 | $13,072 |
| TradjentaLinagliptin | 19 | $12,293 |
| Victoza 3-PakLiraglutide | 12 | $10,687 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,822 |
| Repatha PushtronexEvolocumab | 11 | $6,717 |
| BreynaBudesonide/Formoterol Fumarate | 14 | $3,273 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Sublocade, Suboxone | $11,254 | $47,63449 claims |
| Alkermes, Inc.Vivitrol | $56 | $17,45811 claims |
| AbbVieVraylar | $111 | $17,45613 claims |
| Lilly USA, LLCTrulicity | $14 | $16,69513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 803 family medicine providers in Idaho.
Other family medicine in Gooding
- Kenneth CongerSandpoint$266K
- David ButukMeridian$206K
- Anne BroadwayIdaho Falls$184K
- Timothy McHughMeridian$165K
- Phyllis YouBoise$88K
- Ralph SutherlinSt Maries$73K
- Henry DownsCoeur D Alene$69K
- Crystal PyrakCoeur D Alene$46K
- Gary SoucieBlackfoot$37K
- Julian de Bruyn KopsIdaho Falls$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.